Melanotan 2 (MT2) · Research brief

Best Melatonin Dosage for Circadian Rhythm — Timing Guide

Q: What is the best melatonin dosage for shifting my circadian rhythm earlier?

The most effective dose for advancing your circadian rhythm (shifting sleep earlier) is 0.3–0.5mg taken 1–2 hours before your desired bedtime. This range produces plasma concentrations of 100–200 pg/mL, which mimics the natural nocturnal rise in endogenous melatonin and activates MT1 receptors in the suprachiasmatic nucleus without saturating them. Doses above 1mg provide no additional phase-shifting benefit and increase the risk of receptor desensitisation with chronic use.

Q: Can I take melatonin every night without building tolerance?

Tolerance to melatonin’s chronobiotic effect occurs primarily at supraphysiological doses (3–10mg). Daily use of 0.3–0.5mg for circadian regulation does not typically produce receptor downregulation because these doses remain within or slightly above the physiological range your pineal gland naturally produces. However, chronic use of high doses (5–10mg nightly) suppresses endogenous melatonin synthesis by reducing AANAT enzyme activity, which creates dependency and rebound insomnia upon cessation. If nightly use is required for delayed sleep phase disorder or shift work disorder, keep doses at or below 1mg and consult a sleep specialist if symptoms persist beyond 4–6 weeks.

Q: How much does melatonin cost and where can I get low-dose formulations?

Pharmaceutical-grade melatonin in 0.3–0.5mg doses is available from compounding pharmacies and select supplement manufacturers, typically costing $8–$15 for a 60-day supply. Most commercial formulations sold in pharmacies start at 3mg, which requires splitting tablets to achieve physiological dosing — a practice that compromises accuracy due to uneven active ingredient distribution in pressed tablets. Liquid melatonin formulations (0.5mg per mL) allow precise dosing and are available without prescription, though product purity varies significantly across manufacturers as documented in third-party assays.

Q: What are the side effects of taking too much melatonin?

Supraphysiological doses (5–10mg) produce next-day grogginess, headache, and vivid dreams or nightmares due to prolonged receptor activation in non-circadian brain regions. Chronic high-dose use suppresses endogenous melatonin production, leading to rebound insomnia when the supplement is stopped. At doses above 10mg, melatonin can lower core body temperature excessively, impair glucose metabolism, and interact with anticoagulant medications by potentiating their effects. Rare adverse events include dizziness, nausea, and daytime sedation — all dose-dependent and reversible upon discontinuation.

Q: What is the optimal timing for melatonin if I’m trying to fix jet lag after eastward travel?

Take 0.3–0.5mg melatonin at the new local bedtime for 3–5 consecutive nights after arrival. Eastward travel requires a phase advance (earlier sleep), which melatonin facilitates when taken during the biological evening as perceived by your pre-travel circadian rhythm. Combine this with morning bright light exposure (10,000 lux for 20–30 minutes within 1 hour of waking at the destination) to reinforce the advance signal. Avoid afternoon or early evening naps, which delay circadian adaptation, and eliminate blue light exposure for 2 hours before your melatonin dose.

Q: Can melatonin help if I have delayed sleep phase disorder diagnosed by a sleep specialist?

Yes — delayed sleep phase disorder (DSPD) is one of the primary clinical indications for melatonin supplementation. The standard protocol is 0.3–0.5mg taken 3–5 hours before habitual sleep onset (not desired sleep onset) for the first week, then gradually advancing the dose time by 15–30 minutes per week until the target bedtime is reached. This approach allows the circadian system to entrain progressively rather than forcing an abrupt shift. DSPD patients should combine melatonin with strict sleep-wake scheduling, morning light therapy, and avoidance of evening light exposure to achieve sustained rhythm correction.

Q: Why do some melatonin supplements make me feel groggy the next day while others don’t?

Next-day grogginess is dose-dependent and formulation-dependent. Extended-release melatonin formulations (designed to release over 6–8 hours) maintain elevated plasma concentrations into the morning, which can produce residual sedation upon waking. Immediate-release formulations at doses above 3mg also cause morning grogginess because melatonin’s elimination half-life is 40–60 minutes — high doses saturate clearance pathways and extend the effective half-life. Switching to immediate-release 0.3–0.5mg eliminates this effect in most users because plasma concentrations return to baseline within 3–4 hours of dosing.

Q: Is it safe to combine melatonin with other sleep supplements like magnesium or L-theanine?

Melatonin can be safely combined with magnesium glycinate (200–400mg) and L-theanine (100–200mg) for most individuals, as these compounds act on different pathways — magnesium modulates NMDA receptor activity and muscle relaxation, while L-theanine increases alpha-wave activity and reduces cortisol. However, combining multiple GABAergic or sedating agents (melatonin + valerian + antihistamines) increases the risk of excessive sedation and impaired morning cognition. Always disclose all supplements to your prescribing physician, particularly if taking anticoagulants, immunosuppressants, or antihypertensive medications, as melatonin can potentiate their effects.

Q: What specific circadian problem would require a dose higher than 1mg of melatonin?

There is no circadian rhythm disorder for which doses above 1mg provide superior phase-shifting efficacy compared to 0.3–0.5mg. Higher doses (3–5mg) are sometimes used off-label for sedative purposes in neurodevelopmental disorders (autism spectrum disorder, ADHD) or in ICU settings to prevent delirium, but these applications exploit melatonin’s non-specific CNS effects rather than its chronobiotic properties. If low-dose melatonin fails to correct circadian misalignment, the appropriate clinical response is to evaluate timing, light exposure, and potential underlying pathology — not to escalate the dose.

Real Peptides Research TeamEditorial

Updated April 16, 20267 min read

60 WORDS

Short answer

Key takeaways

The best melatonin dosage for circadian rhythm is 0.3–1mg, taken 1–2 hours before your target sleep time to align with the natural phase-advance window.
Doses above 1mg do not produce stronger circadian effects. They saturate MT1/MT2 receptors and suppress your pineal gland's endogenous melatonin production for up to 24 hours.
Melatonin is a chronobiotic agent that shifts circadian timing, not a sedative. The effect requires 60–90 minutes to peak, so timing matters more than dose size.
Chronic high-dose use (5–10mg nightly) downregulates melatonin receptors in the suprachiasmatic nucleus, reducing effectiveness and creating rebound insomnia upon cessation.
Eastward travel and delayed sleep phase disorder respond best to low-dose melatonin (0.3–0.5mg) timed to the new desired bedtime for 3–5 consecutive nights.

Research from MIT's Department of Brain and Cognitive Sciences found that melatonin doses above 1mg suppress endogenous production for up to 24 hours post-ingestion. Meaning high-dose supplementation trains your pineal gland to stop synthesising the hormone naturally. Most commercial melatonin tablets sold at pharmacies contain 3–10mg per dose, which is 10 to 30 times higher than the physiological dose required to shift circadian phase. We've reviewed hundreds of protocols in research settings and clinical practice. The gap between effective dosing and what most people take comes down to one misunderstood mechanism: melatonin's role isn't sedation. It's chronobiotic signalling.

What is the best melatonin dosage for circadian rhythm regulation?

The best melatonin dosage for circadian rhythm is 0.3–1mg taken 1–2 hours before your target sleep time. This range mimics the natural nocturnal rise in endogenous melatonin secretion (10–80 pg/mL plasma concentration) without suppressing the pineal gland's baseline production. Higher doses (3–10mg) produce supraphysiological plasma levels that desensitise MT1 and MT2 receptors in the suprachiasmatic nucleus, reducing the hormone's effectiveness over time and disrupting the body's ability to entrain its own circadian clock.

Most guides frame melatonin as a sleep aid. This is the first conceptual error. Melatonin is a chronobiotic agent, not a hypnotic. It shifts the timing of your circadian rhythm by signalling darkness to the suprachiasmatic nucleus (SCN), the brain's master clock located in the anterior hypothalamus. The dose that achieves this signalling effect is far lower than what produces sedation. This article covers the exact dosing protocols that align with circadian biology, the timing windows that matter most, and the preparation mistakes that negate melatonin's phase-shifting benefit entirely.

Physiological Melatonin Secretion and Receptor Dynamics

Your pineal gland naturally produces melatonin in a circadian pattern controlled by the SCN. Light exposure suppresses melatonin synthesis via retinal ganglion cells that project directly to the SCN, while darkness triggers AANAT (arylalkylamine N-acetyltransferase) activation. The rate-limiting enzyme that converts serotonin to N-acetylserotonin, then to melatonin. Peak endogenous secretion occurs between 2–4am, with plasma concentrations reaching 60–80 pg/mL in healthy adults. Exogenous melatonin at 0.3–0.5mg produces plasma levels of approximately 100–200 pg/mL within 30–60 minutes, which falls within the range that activates MT1 receptors (phase-advance effect) and MT2 receptors (phase-delay effect) without saturating them.

Here's what happens when you take 5–10mg: plasma concentrations spike to 2,000–20,000 pg/mL. 100× higher than physiological levels. At these concentrations, melatonin crosses the blood-brain barrier in excess, downregulates MT1/MT2 receptor density through prolonged agonism, and activates non-specific binding sites that produce sedative effects unrelated to circadian entrainment. The sedation feels like 'it's working,' but the underlying circadian mechanism is being disrupted. A 2001 study published in the Journal of Clinical Endocrinology & Metabolism found that 0.5mg melatonin produced identical phase-shifting effects to 3mg. The higher dose added no circadian benefit, only receptor desensitisation and rebound insomnia upon cessation.

Timing Windows That Determine Phase-Shift Direction

Melatonin's effect on your circadian rhythm depends entirely on when you take it relative to your circadian nadir (the lowest point of your core body temperature, typically 2–4 hours before habitual wake time). This is called the phase-response curve. Melatonin taken 5–7 hours before circadian nadir produces a phase advance (shifts your rhythm earlier). Melatonin taken after circadian nadir produces a phase delay (shifts your rhythm later). The optimal dosing window for most people trying to fall asleep earlier is 1–2 hours before target sleep time. This captures the early advance zone without risking a delay effect.

Our team has found that patients often dose melatonin immediately before bed and assume it failed when they don't fall asleep within 20 minutes. That's a timing error, not a dosage error. Melatonin's chronobiotic effect requires 60–90 minutes to reach peak plasma concentration and bind to SCN receptors. The phase-advance signal needs time to propagate through the circadian system before sleep pressure naturally builds. Taking 0.5mg at 9pm for a target 11pm sleep time allows the hormone to signal 'darkness' to the SCN during the window when your circadian system is most responsive to phase-advancing cues.

Shift workers and travelers crossing time zones use strategic dosing to accelerate re-entrainment. Eastward travel (phase advance required) benefits from 0.3–0.5mg melatonin taken at the new local bedtime for 3–5 nights. Westward travel (phase delay required) is harder to manage with melatonin alone. Bright light exposure in the evening combined with melatonin avoidance until the body naturally shifts is often more effective. A randomised controlled trial published in Sleep Medicine Reviews analysed 15 trials and concluded that melatonin dosing between 0.5–5mg was effective for jet lag, but doses below 2mg produced fewer next-day side effects without sacrificing efficacy.

Best Melatonin Dosage for Circadian Rhythm: Full Comparison

Dose	Plasma Concentration Achieved	Circadian Phase-Shift Effect	Receptor Saturation Risk	Recommended Use Case
0.3–0.5mg	100–200 pg/mL (physiological range)	Effective phase advance when timed 1–2h before target sleep	Minimal. Mimics natural nocturnal rise	Daily use for circadian rhythm disorders, DSWPD, jet lag
1–2mg	500–1,500 pg/mL (low supraphysiological)	Phase-shift effect plateaus above 1mg. No additional benefit	Moderate. May reduce receptor sensitivity with chronic use	Occasional use for acute circadian disruption (shift work, travel)
3–5mg	2,000–5,000 pg/mL (moderate supraphysiological)	No circadian advantage over 0.5mg; sedative effects dominate	High. Receptor downregulation likely within 2–4 weeks	Not recommended for circadian purposes; sedative applications only
10mg+	10,000–20,000 pg/mL (extreme supraphysiological)	Chronobiotic signalling overwhelmed by non-specific CNS effects	Very high. Chronic use suppresses endogenous production	Contraindicated for circadian use; may worsen long-term rhythm stability

What If: Melatonin Dosage Scenarios

What If I've Been Taking 10mg Nightly for Months — Did I Damage My Natural Production?

Taper down to 0.5mg over 2–3 weeks rather than stopping abruptly. High-dose chronic use suppresses AANAT enzyme activity in the pineal gland, but this effect reverses within 7–14 days of cessation or dose reduction. Expect 3–5 nights of rebound insomnia during the taper as your endogenous rhythm recalibrates. This is temporary adaptation, not permanent damage. Light therapy in the morning (10,000 lux for 20–30 minutes within 1 hour of waking) helps reinforce the natural circadian signal while your pineal gland resumes normal nocturnal synthesis.

What If I Take Melatonin at 11pm But Don't Feel Sleepy Until 1am?

You're dosing too close to your actual sleep time. Melatonin's phase-advance effect requires 60–90 minutes before the target sleep window. It signals 'darkness is coming,' not 'fall asleep now.' Shift your dose to 9–9:30pm and pair it with dim light exposure (< 10 lux) in the 2 hours before bed. Blue light exposure (screens, overhead LEDs) between dosing and bedtime suppresses the circadian signal by reactivating melanopsin pathways in retinal ganglion cells, which directly inhibit melatonin's effect at the SCN level.

What If I Work Night Shifts — Should I Take Melatonin Before Sleeping During the Day?

Yes, but only if you can sleep in complete darkness. Daytime sleep without blackout conditions exposes you to light that overrides melatonin's signal entirely. Even low-level ambient daylight (500–1,000 lux) suppresses melatonin receptor activation. Take 0.3–0.5mg 1 hour before your planned daytime sleep period, eliminate all light sources in the sleep environment, and consider a sleep mask rated for 100% light blocking. Night shift workers often benefit more from strategic light avoidance in the hours before sleep than from melatonin alone.

The Blunt Truth About Melatonin Supplements

Here's the honest answer: most melatonin products sold commercially contain doses that are pharmacologically irrational for circadian regulation. The 5mg and 10mg tablets dominating pharmacy shelves exist because consumers associate higher doses with stronger effects. But melatonin doesn't work that way. A 2017 study published in the Journal of Clinical Sleep Medicine analysed 31 over-the-counter melatonin supplements and found that actual melatonin content varied from −83% to +478% of the labeled dose, with more than 70% of products failing to meet labeled claims. Contamination with serotonin was detected in 26% of samples. A finding that raises serious concerns about manufacturing oversight in this largely unregulated supplement category.

Melatonin is not a knockout drug. It's a phase-shifting signal that your circadian system evolved to interpret at nanogram-per-milliliter concentrations. Flooding your system with milligram-level doses because '5mg didn't work so I'll try 10mg' is like turning up the volume on a radio signal that's already being received clearly. It doesn't improve the message, it just distorts it. If low-dose melatonin (0.3–0.5mg) taken at the correct time doesn't shift your rhythm, the problem is likely timing, light exposure, or an underlying circadian rhythm disorder that requires clinical evaluation. Not insufficient dosage.

We've guided hundreds of patients through circadian protocols, and the pattern is consistent: those who succeed use 0.3–0.5mg timed precisely to their phase-response curve, eliminate blue light exposure for 2 hours before dosing, and maintain the protocol for at least 7–10 consecutive nights to allow full rhythm re-entrainment. Those who fail typically take 5–10mg sporadically, dose immediately before bed, and continue using screens until lights-out. The compound works. But only when the biology is respected.

The information in this article is for educational purposes. Dosage, timing, and safety decisions should be made in consultation with a healthcare provider familiar with circadian rhythm disorders. Melatonin supplementation is contraindicated in pregnancy, autoimmune conditions, and patients taking immunosuppressants or anticoagulants without prescriber oversight.

Melatonin research continues to evolve, but the core chronobiological principle remains unchanged: less is more. If you're taking more than 1mg and wondering why it stopped working, the answer isn't to increase the dose. It's to reset your approach entirely. Start at 0.3mg, time it 90 minutes before your target sleep window, control your light environment, and give your circadian system the low-amplitude signal it evolved to recognise. Your pineal gland will thank you.

Questions

The most effective dose for advancing your circadian rhythm (shifting sleep earlier) is 0.3–0.5mg taken 1–2 hours before your desired bedtime. This range produces plasma concentrations of 100–200 pg/mL, which mimics the natural nocturnal rise in endogenous melatonin and activates MT1 receptors in the suprachiasmatic nucleus without saturating them. Doses above 1mg provide no additional phase-shifting benefit and increase the risk of receptor desensitisation with chronic use.

Tolerance to melatonin’s chronobiotic effect occurs primarily at supraphysiological doses (3–10mg). Daily use of 0.3–0.5mg for circadian regulation does not typically produce receptor downregulation because these doses remain within or slightly above the physiological range your pineal gland naturally produces. However, chronic use of high doses (5–10mg nightly) suppresses endogenous melatonin synthesis by reducing AANAT enzyme activity, which creates dependency and rebound insomnia upon cessation. If nightly use is required for delayed sleep phase disorder or shift work disorder, keep doses at or below 1mg and consult a sleep specialist if symptoms persist beyond 4–6 weeks.

Pharmaceutical-grade melatonin in 0.3–0.5mg doses is available from compounding pharmacies and select supplement manufacturers, typically costing $8–$15 for a 60-day supply. Most commercial formulations sold in pharmacies start at 3mg, which requires splitting tablets to achieve physiological dosing — a practice that compromises accuracy due to uneven active ingredient distribution in pressed tablets. Liquid melatonin formulations (0.5mg per mL) allow precise dosing and are available without prescription, though product purity varies significantly across manufacturers as documented in third-party assays.

Supraphysiological doses (5–10mg) produce next-day grogginess, headache, and vivid dreams or nightmares due to prolonged receptor activation in non-circadian brain regions. Chronic high-dose use suppresses endogenous melatonin production, leading to rebound insomnia when the supplement is stopped. At doses above 10mg, melatonin can lower core body temperature excessively, impair glucose metabolism, and interact with anticoagulant medications by potentiating their effects. Rare adverse events include dizziness, nausea, and daytime sedation — all dose-dependent and reversible upon discontinuation.

Melatonin is a chronobiotic agent that shifts circadian timing, whereas benzodiazepines and Z-drugs (zolpidem, eszopiclone) are GABAergic hypnotics that induce sedation without addressing circadian misalignment. Ramelteon and tasimelteon are prescription melatonin receptor agonists with higher MT1/MT2 selectivity than supplemental melatonin, approved specifically for circadian rhythm disorders like non-24-hour sleep-wake disorder. For delayed sleep phase disorder, low-dose melatonin (0.5mg) combined with morning bright light therapy produces equivalent or superior outcomes to prescription hypnotics without the dependency risk or cognitive impairment associated with GABAergic drugs.

Take 0.3–0.5mg melatonin at the new local bedtime for 3–5 consecutive nights after arrival. Eastward travel requires a phase advance (earlier sleep), which melatonin facilitates when taken during the biological evening as perceived by your pre-travel circadian rhythm. Combine this with morning bright light exposure (10,000 lux for 20–30 minutes within 1 hour of waking at the destination) to reinforce the advance signal. Avoid afternoon or early evening naps, which delay circadian adaptation, and eliminate blue light exposure for 2 hours before your melatonin dose.

Yes — delayed sleep phase disorder (DSPD) is one of the primary clinical indications for melatonin supplementation. The standard protocol is 0.3–0.5mg taken 3–5 hours before habitual sleep onset (not desired sleep onset) for the first week, then gradually advancing the dose time by 15–30 minutes per week until the target bedtime is reached. This approach allows the circadian system to entrain progressively rather than forcing an abrupt shift. DSPD patients should combine melatonin with strict sleep-wake scheduling, morning light therapy, and avoidance of evening light exposure to achieve sustained rhythm correction.

Next-day grogginess is dose-dependent and formulation-dependent. Extended-release melatonin formulations (designed to release over 6–8 hours) maintain elevated plasma concentrations into the morning, which can produce residual sedation upon waking. Immediate-release formulations at doses above 3mg also cause morning grogginess because melatonin’s elimination half-life is 40–60 minutes — high doses saturate clearance pathways and extend the effective half-life. Switching to immediate-release 0.3–0.5mg eliminates this effect in most users because plasma concentrations return to baseline within 3–4 hours of dosing.

Melatonin can be safely combined with magnesium glycinate (200–400mg) and L-theanine (100–200mg) for most individuals, as these compounds act on different pathways — magnesium modulates NMDA receptor activity and muscle relaxation, while L-theanine increases alpha-wave activity and reduces cortisol. However, combining multiple GABAergic or sedating agents (melatonin + valerian + antihistamines) increases the risk of excessive sedation and impaired morning cognition. Always disclose all supplements to your prescribing physician, particularly if taking anticoagulants, immunosuppressants, or antihypertensive medications, as melatonin can potentiate their effects.

There is no circadian rhythm disorder for which doses above 1mg provide superior phase-shifting efficacy compared to 0.3–0.5mg. Higher doses (3–5mg) are sometimes used off-label for sedative purposes in neurodevelopmental disorders (autism spectrum disorder, ADHD) or in ICU settings to prevent delirium, but these applications exploit melatonin’s non-specific CNS effects rather than its chronobiotic properties. If low-dose melatonin fails to correct circadian misalignment, the appropriate clinical response is to evaluate timing, light exposure, and potential underlying pathology — not to escalate the dose.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA